Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
medicine
The pneumonia severity index predicts time to clinical stability in patients with community-acquired pneumonia
International Journal of Tuberculosis and Lung Disease, Volume 10, No. 7, Year 2006
Notification
URL copied to clipboard!
Description
SETTING: A total of 33 hospitals in 13 countries in North America, Europe, Africa, Asia and Latin America. OBJECTIVE: To investigate the relationship between the pneumonia severity index (PSI) and the time to clinical stability from intravenous to oral antibiotic therapy in hospitalized adult patients with community-acquired pneumonia (CAP). DESIGN: An international, retrospective, observational study of random adult patients meeting the definition of CAP between June 2001 and May 2004. RESULTS: The risk class (RC) according to the PSI was calculated for all patients. The criteria to define when a patient is clinically stable were evaluated daily during the first 7 days of hospitalization in all patients. The mean time to clinical stability for 254 patients in RC I was 4.2 days, for 233 patients in RC II it was 3.9 days, for 395 patients in RC III it was 4.6 days, for 644 patients in RC IV it was 5.0 days and for 296 patients in RC V it was 6.0 days. Significant positive correlations were observed between RC and time to clinical stability (P < 0.0001). CONCLUSION: The PSI is a tool that can be used to predict time to clinical stability (i.e., time to antimicrobial switch therapy) in hospitalized patients with CAP. © 2006 The Union.
Authors & Co-Authors
Arnold, Forest W.
United States, Louisville
University of Louisville
LaJoie, Andrew Scott
United States, Louisville
University of Louisville
Marrie, Thomas James
Canada, Edmonton
University of Alberta Hospital
Rossi, Paolo
Italy, Udine
Presidio Ospedaliero Universitario Santa Maria Della Misericordia , Udine
Blasi, Francesco B.
Italy, Milan
Università Degli Studi Di Milano
Luna, Carlos Marcelo
Argentina, Buenos Aires
Hospital de Clínicas José de San Martín
Fernandez, P.
Chile, Santiago
Instituto Nacional Del Tórax
Porras, J.
Canada, Montreal
University of Montreal
Weiss, Karl A.
Canada, Montreal
Hôpital Maisonneuve-rosemont
Feldman, Charles
South Africa, Johannesburg
Charlotte Maxeke Johannesburg Academic Hospital
Rodriguez, E.
Argentina, Buenos Aires
Hospital Espanol
Levy, G.
Venezuela, Caracas
Hospital Universitario de Caracas
Arteta, F.
Venezuela, Barquisimeto
Asociación Cardiovascular Centroccidental, Venezuela
Roig, J.
Andorra, Escaldes-engordany
Hospital Nostra Senyora de Meritxell
Rello, Jordi
Spain, Tarragona
Hospital Universitario Joan Xxiii de Tarragona
Ramirez, Julio A.
United States, Louisville
University of Louisville
Statistics
Citations: 16
Authors: 16
Affiliations: 14
Identifiers
ISSN:
10273719
Research Areas
Health System And Policy
Study Design
Cohort Study